Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.
about
Towards tumor immunodiagnosticsTumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast CancerTumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesPrognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.Disease evolution and heterogeneity in bilateral breast cancer.The fate of BRCA1-related germline mutations in triple-negative breast tumors.Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis.The Predictive and Prognostic Role of Stromal Tumor-infiltrating Lymphocytes in HER2-positive Breast Cancer with Trastuzumab-based Treatment: a Meta-analysis and Systematic Review.Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer.Role of sialyl 6-sulfo Lewis X in antitumor immunity against oral squamous cell carcinoma.Tumor Immuno-Environment in Cancer Progression and Therapy.Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy
P2860
Q26738691-48833F4E-70D1-4D5B-8A4C-883E4F7C34B2Q26745446-5699B661-0CB6-48A2-9C6F-C5AE728FBAB1Q28554412-BD0BC9EB-28BE-4681-86B3-B2ABB783DBC8Q33646271-7FEA1082-0DDB-437C-8A28-C4C959F81E95Q37447919-A52884C0-1D43-481F-B75B-CED01D02AFD9Q37596828-B522D68C-EB2D-4C16-8A54-DE0498541F93Q37733061-D09A6D7A-BB2C-412E-95C4-640961DDB3F6Q38734804-53536AF4-CE55-4220-8E09-856787B8C2D6Q38935248-7E860492-7D6A-4B05-9041-C0EBF4A1ACBEQ39638185-1C2D3035-B714-451D-963E-3A506D793B0EQ42730619-72C375B0-92EE-489E-9DEF-00F85F9B7EBDQ47109695-D6F257DE-6530-4383-88C5-7658EB0668ABQ47734351-5CDEEB83-0AF3-4A79-96D2-E73CA1EBE3ADQ48255602-52B6E7EE-A720-4DC4-9192-4987614960F0Q49592937-AEC8444F-0D34-4A95-9079-0A13B48B8DEFQ57152794-B3C743BA-0C3A-474A-92EF-F7E297FD2B09
P2860
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumors with high-density tumor ...... r prospective adjuvant trials.
@en
type
label
Tumors with high-density tumor ...... r prospective adjuvant trials.
@en
prefLabel
Tumors with high-density tumor ...... r prospective adjuvant trials.
@en
P2093
P2860
P356
P1433
P1476
Tumors with high-density tumor ...... r prospective adjuvant trials.
@en
P2093
Amanda Psyrri
Angelos Koutras
Dimitrios Pectasides
Eleni Galani
Eleni Timotheadou
Epaminontas Samantas
Flora Zagouri
George Pentheroudakis
Gerasimos Aravantinos
Helen Gogas
P2860
P304
P356
10.18632/ONCOTARGET.6231
P407
P577
2015-10-25T00:00:00Z